Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Journal of the American Geriatrics Society|January 1, 1985
Psychiatric assessment of elderly patients in the home: a survey of 176 casesM T LevyJournal of Hepatology|March 9, 2000
Oncostatin M: a cytokine upregulated in human cirrhosis, increases collagen production by human hepatic stellate cellsM T Levy, M Trojanowska, A ReubenArchives of Internal Medicine|October 10, 1994
Hypertensive disorders of pregnancy in southwestern Navajo IndiansM T Levy, S J Jacober, J R SowersLiver|May 25, 2002
Intrahepatic expression of the hepatic stellate cell marker fibroblast activation protein correlates with the degree of fibrosis in hepatitis C virus infectionM T Levy, G W McCaughan, G Marinos, et al.Journal of Gastroenterology and Hepatology|August 1, 1996
Case report: delayed resolution of severe pulmonary hypertension after isolated liver transplantation in a patient with cirrhosisM T Levy, P Torzillo, M Bookallil, et al.European Journal of Biochemistry|December 3, 1999
Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domainC A Abbott, G W McCaughan, M T Levy, et al.Advances in Experimental Medicine and Biology|June 13, 2000
Relating structure to function in the beta-propeller domain of dipeptidyl peptidase IV. Point mutations that influence adenosine deaminase binding, antibody binding and enzyme activityM D Gorrell, C A Abbott, T Kähne, et al.Journal of Gastroenterology and Hepatology|June 1, 1997
Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: referral patterns and transplant outcomesM T Levy, J J Chen, P H McGuinness, et al.Hepatology (Baltimore, Md.)|May 29, 1999
Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosisM T Levy, G W McCaughan, C A Abbott, et al.ESMO Gastrointestinal Oncology|February 6, 2026
The Liver Frailty Index predicts survival in systemic therapy for hepatocellular carcinoma: a multicentre prospective cohort studyK M J Waller, D S Prince, E H Y Lai, et al.Pageof 2